Publication | Closed Access

1044 TELAPREVIR IN HEPATITIS C GENOTYPE-1-INFECTED PATIENTS WITH PRIOR NON-RESPONSE, VIRAL BREAKTHROUGH OR RELAPSE TO PEGINTERFERON- ALFA-2A/B AND RIBAVIRIN THERAPY: SVR RESULTS OF THE PROVE3 STUDY

HepatologyHepatitis CViral HepatitisImmunodeficienciesAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirologySvr ResultsAntiviral DrugThe Prove3 StudyMedicineViral Immunity